CytoMed Therapeutics Ltd. filed an update on June 24, 2024, regarding the resignations of Dr. Lucas Luk and Mr. Wu Tao from its Board effective May 15, 2024, for personal reasons. Dr. Luk remains with the company as Chief Clinical Officer and now serves on its subsidiary's board, while Mr. Yew Chak Hua joins the audit committee to maintain compliance.